-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On 5 August, CDE published the Chemical Generics Participating Preparations Catalog (32nd Batch), covering a total of 65 varieties (in the name of the drug), 18 of which were injections and 1 was inhalers.
2019, three injections will have terminal sales of more than 2 billion yuan in China's public medical institutions, according to data from the 100-meter intranet.
In CDE's newly announced list of relevant preparations, covering a number of large varieties of heavy injections, including volicazole for injection, potassium amoxicillin for injection, tyrone for injection, etc., in 2019 China's urban public hospitals, county-level public hospitals, urban community centers and township health hospitals (referred to as China's public medical institutions) terminal sales of more than 2 billion yuan.
Figure 1: Injection Voliconazole consistency evaluation declaration of the rice net data show that the injection of Voliconazole has not been evaluated by enterprises, 6 enterprises have laid out the product consistency evaluation, including Qilu, Yangzijiang, Hainan, etc.
6 enterprises are reported in the new classification, after the approval of production will be treated as through consistency evaluation.
Figure 2: Injection with tyrone consistency evaluation declaration of injection with tyrone has not yet been evaluated by enterprises, 6 enterprises have laid out the product consistency evaluation, including Osecon, Zheng Datianqing, Howson and so on.
Jianyou Biochemicals in Nanjing with a new classification, the remaining five enterprises have submitted a consistency evaluation supplementary application.
aerosols are the only inhalants in this catalog that can relieve asthma symptoms and allergic rhinitis by inhaling aerosols.
no domestic products have been evaluated, four Trump Sharp Pharmaceuticals exclusive to copy 3 categories of declared clinical, and in October 2017 was approved clinical.
: Chemical generics referral preparation catalog (32nd batch) (draft for comments) Source: In-network database, CDE Note: data statistics as of August 6, if there are omissions, welcome to point the right!